| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.5 | 0.003 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.23 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |